From: Does postoperative chemotherapy improve overall survival of patients with ypT1-2N0 cancer?
Variable | Univariable analysis | Multivariable analysis | ||
---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | p value | |
Age (years) | 1.017 (0.991–1.043) | 0.193 | – |  |
Gender |  |  | – |  |
 Female | 1 (ref.) |  |  |  |
 Male | 1.033 (0.533–2.004) | 0.923 |  |  |
BMI | 1.057 (0.952–1.175) | 0.297 | – |  |
Tumor size (cm) | 1.191 (0.909–1.560) | 0.204 |  |  |
Clinical T stage | ||||
 cT2 | 1 (ref.) |  | 1 (ref.) |  |
 cT3 | 3.073 (0.991–9.532) | 0.052 | 2.875 (0.998–8.281) | 0.050 |
 cT4 | 5.685 (1.405–23.002) | 0.015 | 7.382 (2.569–21.211) | < 0.001 |
Clinical nodal status | ||||
 cN− | 1 (ref.) |  | 1 (ref.) |  |
 cN+ | 1.974 (1.010–3.860) | 0.047 | 1.099 (0.430–2.807) | 0.343 |
No. of NACT cycles |  |  | – |  |
 2 | 1 (ref.) |  |  |  |
 3 | 1.266 (0.456–3.516) | 0.651 |  |  |
 4 | 0.574 (0.212–1.559) | 0.276 |  |  |
Tumor location |  |  | – |  |
 Upper third | 1 (ref.) |  |  |  |
 Middle third | 1.211 (0.560–2.619) | 0.627 |  |  |
 Lower third | 0.641 (0.277–1.484) | 0.299 |  |  |
Type of resection |  |  | – |  |
 Subtotal | 1 (ref.) |  |  |  |
 Total | 1.264 (0.658–2.429) | 0.482 |  |  |
Lauren type |  |  | – |  |
 Intestinal | 1 (ref.) |  |  |  |
 Diffuse/mixed | 1.405 (0.725–2.726) | 0.314 |  |  |
Differentiation | ||||
 Well/moderate | 1 (ref.) |  | 1 (ref.) |  |
 Poor | 1.883 (0.978–3.623) | 0.058 | 1.399 (0.537–3.645) | 0.492 |
Signet ring cell |  |  | – |  |
 No | 1 (ref.) |  |  |  |
 Yes | 1.674 (0.867–3.231) | 0.125 |  |  |
Pathological T stage |  |  | – |  |
 ypT1 | 1 (ref.) |  |  |  |
 ypT2 | 1.237 (0.619–2.474) | 0.547 |  |  |
No. of lymph nodes | 1.031 (0.947–1.122) | 0.487 | – |  |
Lymphovascular invasion | ||||
 No | 1 (ref.) |  | 1 (ref.) |  |
 Yes | 1.770 (0.920–3.403) | 0.052 | 1.029 (0.408–2.598) | 0.251 |
Pathological response |  |  | – |  |
 CAP 0 | 1 (ref.) |  |  |  |
 CAP 1 | 1.701 (0.512–5.651) | 0.386 |  |  |
 CAP 2 | 1.550 (0.494–4.870) | 0.453 |  |  |
 CAP 3 | 2.352 (0.767–7.219) | 0.135 |  |  |
Postoperation chemotherapy | ||||
 No | 1 (ref.) |  |  |  |
 Yes | 0.910 (0.473–1.750) | 0.777 |  |  |